Clinical value of urethral dilation in treatment of female bladder outlet obstruction

Abstract

Objective To explore the clinical value of urethral dilation in treatment of female bladder outlet obstruction. Methods Thirty- five female bladder outlet obstruction patients were selected, and all the patients failed for more than 1 month in α receptor blocker treatment. The patients underwent urethral dilation under local anaesthesia, once a week, for a total of 12 times. The international prostate symptom score (IPSS), quality of life score (QOL) and residual urine volume before and after treatment were examined. Results The IPSS, QOL and residual urine volume after treatment were significantly lower than those before treatment: (10.23 ± 6.31) scores vs. (21.41 ± 3.71) scores, (2.31 ± 0.65) scores vs. (5.43 ± 0.60) scores and (20.73 ± 10.59) ml vs. (85.23 ± 12.15) ml, and there were statistical differences (P<0.01). Conclusions The urethral dilation is one of the effective treatments for female bladder outlet obstruction patients who fail in α receptor blocker treatment. It can make a part of patients avoid invasive examination and surgery, and it is worth to be popularized in clinic and primary hospital. Key words: Urethral obstruction; Dilatation; Female; Retrospective studies